After the close, RXi Pharmaceuticals Corporation (Nasdaq: RXII) announced that Dmitry Samarsky, Ph.D., Vice President of Technology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE